SCHEMBL24853596

SCHEMBL24853596

C/C=C(\C)c1nc2ccccc2c2cc([Si](C)(C)C)oc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.36
▸ TLR8 Q9NR97 1/20 0.35
▸ GPR3 P46089 2/20 0.33
▸ ELANE P08246 7/20 0.33
▸ CYP1A2 P05177 1/20 0.32
▸ MAPT P10636 4/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ LMNA P02545 2/20 0.31
▸ KDM4E B2RXH2 2/20 0.31
▸ GAA P10253 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ USP2 O75604 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ MEN1 O00255 2/20 0.30
▸ KMT2A Q03164 2/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ HSP90AA1 P07900 1/20 0.30
▸ RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24853807 0.89 ALDH1A1 (0.42) ALDH1A1ELANECYP1A2MAPTSMN1; SMN2
SCHEMBL24854100 0.75 GPR3 (0.36) ALDH1A1GPR3ELANECYP1A2MAPT
SCHEMBL24853587 0.70 ALDH1A1 (0.36) ALDH1A1GPR3ELANEMAPTSMN1; SMN2
SCHEMBL24853579 0.69 TP53 (0.34) TLR8ELANECYP1A2MAPTSMN1; SMN2
SCHEMBL24853790 0.67 GPR3 (0.36) ALDH1A1GPR3MAPTSMN1; SMN2KDM4E
SCHEMBL24853588 0.67 ALDH1A1 (0.40) ALDH1A1MAPTSMN1; SMN2LMNAKDM4E
SCHEMBL22431673 0.64 CSNK2A1 (0.38) ALDH1A1TLR8GPR3MAPTSMN1; SMN2
SCHEMBL24853805 0.64 ELANE (0.40) ALDH1A1ELANESMN1; SMN2KDM4EHPGD
SCHEMBL24853605 0.61 ALDH1A1 (0.40) ALDH1A1MAPTSMN1; SMN2LMNAKDM4E
SCHEMBL18576588 0.59 CYP2A6 (0.52) ALDH1A1MAPTSMN1; SMN2LMNACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002427-A1 ORGANOMETALLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-01-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002427-A1 ORGANOMETALLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME NONO, BMI1, LIG1 ALDH1A1 745/4885TLR8 4464/4885GPR3 4622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback